Obstructive sleep apnea (OSA) is common, serious, and highly treatable. While CPAP therapy has been the gold standard for decades, many people struggle to use it consistently. That’s where Inspire therapy, a type of hypoglossal nerve stimulation (HNS), comes in. At Norelle Health, Inspire therapy offers an alternative for adults with moderate to severe OSA who can’t tolerate CPAP. In this guide, we’ll explain how Inspire works, who qualifies, and what results you can expect.
Request Consultation
Understanding Obstructive Sleep Apnea and the Role of Hypoglossal Nerve Stimulation
OSA occurs when the upper airway collapses during sleep, causing airflow to stop and start. This happens because:
The tongue and soft tissues relax and can block the airway.
Anatomy plays a role: a large tongue base, long soft palate, or thick lateral walls increase the risk of collapse.
Physiological factors, like a highly sensitive breathing control system, can make breathing unstable.
CPAP works by pressurizing the airway, keeping it open. But adherence is a challenge for many due to mask discomfort, dryness, claustrophobia, or noise. Oral appliances help those with milder disease or jaw alignment issues, but they often fall short when tongue-base collapse or higher BMI is involved.
Hypoglossal nerve stimulation addresses the problem directly: it activates the tongue’s forward-moving muscles with each breath, stiffening the airway and reducing collapse. For patients with primarily anatomical collapse at the tongue base, HNS can be life-changing.
Learn more about Inspire therapy at Norelle Health.
Request Consultation
How Inspire Therapy Works
Think of Inspire as a smart, breath-synced pacemaker for your tongue. It includes three implanted components plus a remote:
Implantable pulse generator (IPG): Sits under the skin in the chest and powers the system.
Respiratory sensing lead: Detects inhalation through intercostal activity.
Stimulation lead: Wraps around branches of the hypoglossal nerve to activate tongue muscles.
The system delivers precise, timed stimulation during inhalation to keep the airway open. Patients can adjust settings within safe ranges using a handheld remote. Small features like a start delay and ramp-up function make it easy to live with.
Surgical and post-op process:
Outpatient procedure under general anesthesia with three small incisions.
One-month healing period before activation.
Gradual at-home adjustments, with a titration sleep study at 2–3 months to optimize therapy.
Schedule an Inspire consultation to see if this therapy could be right for you.
Who Is a Candidate?
Ideal candidates are adults with moderate to severe OSA who have:
A documented CPAP intolerance (less than 4 hours/night on most nights).
A BMI typically ≤35 (up to 40 in select cases).
Low central apnea burden (≤25% of total events).
Anatomically driven airway collapse without complete concentric palatal collapse (assessed with Drug-Induced Sleep Endoscopy, or DISE).
Special populations, like select adolescents with Down syndrome and persistent OSA, may also qualify.
Important: Certain conditions, such as severe cardiopulmonary disease or tongue dysfunction, may prevent candidacy. Discuss your history and questions with a sleep specialist or ENT.
Find a sleep specialist experienced with Inspire.
Request Consultation
Clinical Outcomes and Safety
Studies demonstrate strong, lasting results for carefully selected patients:
STAR Trial: In CPAP-intolerant adults with moderate to severe OSA, Inspire therapy reduced the apnea–hypopnea index (AHI) by roughly two-thirds at 12 months. Improvements were also seen in oxygen saturation, daytime alertness, and overall quality of life, with benefits maintained over longer-term follow-up.
ADHERE Registry: Real-world data from thousands of patients confirm durable improvements in AHI, better sleep quality, and high adherence, with most using the device nightly for around 5–6 hours.
Safety Profile: Inspire is generally well-tolerated. Early postoperative issues may include incision discomfort, temporary tongue tingling, or minor speech changes, but these typically resolve with device programming adjustments. The generator battery lasts 10–12 years and can be replaced in an outpatient procedure, while leads usually remain in place.
Comparisons with Other Therapies:
CPAP: Remains the gold standard when tolerated, normalizing AHI and providing cardiometabolic benefits.
Mandibular Advancement Devices (MADs): Effective for mild to moderate OSA, especially with retrognathia, but may not adequately reduce AHI in cases of significant tongue-base collapse.
Upper Airway Surgeries: Can be effective depending on anatomy but are more invasive and less adjustable. Inspire offers a reversible, tunable option with strong long-term adherence and consistent results.
This evidence highlights Inspire therapy as a safe, durable, and patient-friendly alternative for those who cannot tolerate CPAP, delivering meaningful improvements in sleep quality and daily functioning.
Contact Us
Practical Considerations
Recovery & Follow-Up
Most patients go home the same day, with manageable discomfort. Device activation occurs about four weeks post-surgery, and stimulation is gradually adjusted at home. Snoring often improves early, while daytime alertness builds over several weeks.
Coverage & Insurance
Medicare and many commercial insurers cover Inspire for eligible patients, though prior authorization is required. Documentation of CPAP intolerance and sleep study results is typically needed.
Special Populations & Future Advances
Inspire may be combined with positional therapy, weight management, or low-pressure CPAP. New technologies, including smarter algorithms, leadless devices, and longer battery life, are improving comfort and expanding options for patients.
Who Benefits Most?
Patients with:
Moderate to severe Obstructive sleep apnea (OSA) with mainly obstructive events.
Tongue-base or front-to-back palatal collapse (without CCC).
BMI within program limits.
CPAP intolerance despite optimization.
Patients with severe central sleep apnea or CCC may benefit from alternative therapies.
Key Takeaways
Inspire therapy is a safe, well-studied alternative for adults with moderate–severe OSA who cannot tolerate CPAP.
It works by sensing your breath and stimulating the hypoglossal nerve to keep the airway open.
Proper patient selection, DISE evaluation, and structured follow-up are critical for success.
Results are durable: AHI drops, snoring fades, and sleep quality improves.
Inspire therapy can turn sleep from a nightly struggle into a comfortable, reliable routine for adults with anatomically driven OSA who cannot tolerate CPAP. While it isn’t a replacement for successful CPAP use, careful evaluation, skilled implantation, and ongoing follow-up make it a safe, effective, long-term solution. Start your journey to better sleep. Contact Norelle Health today to see if Inspire therapy is right for you, and bring your CPAP history, latest sleep study, and questions to your consultation.
Request Consultation